SARS-CoV-2 Bacillus subtilis

Atiqah Hazan1, Amalia A Saperi1, Nurfatihah Zulkifli1

  • 1Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, 50603, Malaysia.

BMC microbiology
|October 6, 2025
PubMed
概括

在口服后,表达SARS-CoV-2尖端蛋白的重组细菌细菌子在小鼠中没有显示出毒性. 这支持它们作为安全的口服疫苗候选人对抗COVID-19的潜力.